Cocaine potently blocks neuronal α
SH-SY5Y cells
cocaine
nicotinic acetylcholine receptor
open-channel block
patch-clamp
Journal
Acta pharmacologica Sinica
ISSN: 1745-7254
Titre abrégé: Acta Pharmacol Sin
Pays: United States
ID NLM: 100956087
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
06
01
2019
accepted:
23
06
2019
pubmed:
11
8
2019
medline:
24
10
2020
entrez:
11
8
2019
Statut:
ppublish
Résumé
Cocaine is one of the most abused illicit drugs worldwide. It is well known that the dopamine (DA) transporter is its major target; but cocaine also acts on other targets including nicotinic acetylcholine receptors (nAChRs). In this study, we investigated the effects of cocaine on a special subtype of neuronal nAChR, α
Identifiants
pubmed: 31399700
doi: 10.1038/s41401-019-0276-y
pii: 10.1038/s41401-019-0276-y
pmc: PMC7471406
doi:
Substances chimiques
Receptors, Nicotinic
0
nicotinic receptor alpha3beta4
0
nicotinic receptor alpha4beta2
0
Nicotine
6M3C89ZY6R
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
163-172Subventions
Organisme : NIDA NIH HHS
ID : R01 DA011064
Pays : United States
Références
Mol Pharmacol. 2000 Jul;58(1):109-19
pubmed: 10860932
Mol Cell Neurosci. 1993 Feb;4(1):1-12
pubmed: 19912902
Biochemistry. 2004 Jan 20;43(2):481-9
pubmed: 14717603
Neuron. 1999 Nov;24(3):649-58
pubmed: 10595516
Behav Brain Res. 2006 Mar 15;168(1):120-6
pubmed: 16313978
J Biol Chem. 2004 Sep 3;279(36):37842-51
pubmed: 15234980
Biochem Pharmacol. 2015 Oct 15;97(4):531-541
pubmed: 26256075
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5185-90
pubmed: 16537435
Neuropsychopharmacology. 2001 May;24(5):576-89
pubmed: 11282258
JAMA. 1994 Dec 14;272(22):1724
pubmed: 7966914
J Pharmacol Exp Ther. 2011 Nov;339(2):678-86
pubmed: 21856860
Biol Psychiatry. 2008 Jun 1;63(11):1039-46
pubmed: 18163978
J Neurophysiol. 2005 Nov;94(5):3081-91
pubmed: 16033935
Cancer Res. 2009 Sep 1;69(17):6848-56
pubmed: 19706762
Pflugers Arch. 2018 Jan;470(1):21-27
pubmed: 29058146
Front Pharmacol. 2019 Feb 14;10:72
pubmed: 30837868
Neuropsychopharmacology. 2008 Jul;33(8):1779-97
pubmed: 17928814
J Pharmacol Exp Ther. 2004 Oct;311(1):80-91
pubmed: 15178698
J Physiol. 2009 Jan 15;587(2):345-61
pubmed: 19047205
Eur Neuropsychopharmacol. 2005 Mar;15(2):219-25
pubmed: 15695068
Eur Neuropsychopharmacol. 2010 Feb;20(2):69-79
pubmed: 19959340
Neurotoxicology. 2004 Dec;25(6):967-80
pubmed: 15474615
Mol Psychiatry. 2008 Apr;13(4):368-73
pubmed: 18227835
J Med Chem. 2012 Nov 26;55(22):9929-45
pubmed: 23025891
J Pharmacol Exp Ther. 1995 Jul;274(1):396-403
pubmed: 7616424
PLoS One. 2009;4(2):e4653
pubmed: 19247474
Neuropsychopharmacology. 2015 Jan;40(2):350-60
pubmed: 25035086
Neuropsychopharmacology. 2014 Jul;39(8):1843-51
pubmed: 24513971
J Pharmacol Exp Ther. 2003 Jun;305(3):1132-41
pubmed: 12626641
Science. 1987 Sep 4;237(4819):1219-23
pubmed: 2820058
Psychopharmacology (Berl). 2006 Aug;187(2):181-8
pubmed: 16826402
Neuropharmacology. 1999 Jun;38(6):769-83
pubmed: 10465681
Sci Transl Med. 2011 Nov 2;3(107):107ra109
pubmed: 22049069
Nature. 2008 Apr 3;452(7187):638-642
pubmed: 18385739
Brain Res Bull. 2010 Jan 15;81(1):120-4
pubmed: 19665529
Acta Pharmacol Sin. 2018 Oct;39(10):1571-1581
pubmed: 29795357
J Physiol. 2006 Oct 1;576(Pt 1):103-18
pubmed: 16825297
J Neurochem. 2002 Aug;82(3):468-81
pubmed: 12153472
J Neurosci. 2001 Mar 1;21(5):1452-63
pubmed: 11222635
J Neurosci. 2002 Apr 15;22(8):3269-76
pubmed: 11943828
Front Synaptic Neurosci. 2014 Sep 04;6:19
pubmed: 25237305
Eur J Pharmacol. 2019 Feb 15;845:1-7
pubmed: 30529197
J Pharmacol Exp Ther. 1999 Jun;289(3):1229-36
pubmed: 10336510
Mol Pharmacol. 2003 Dec;64(6):1283-94
pubmed: 14645658
Biochem Pharmacol. 2009 Oct 1;78(7):703-11
pubmed: 19481063